Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cells, Tissues, Organs|February 20, 2017
Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal TransitionDuane H Hamilton, Justin M David, Charli Dominguez, et al.
Vaccines|June 28, 2016
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune ResistanceJustin M David, Charli Dominguez, Duane H Hamilton, et al.
Cancer Immunology Research|May 19, 2025
Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in CancerMaria Gracia-Hernandez, Maria Del Mar Maldonado, Jeffrey Schlom, et al.
Cancer Research|June 10, 2011
IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cellsRomaine I Fernando, Marianne D Castillo, Mary Litzinger, et al.
Cancer Research|March 15, 2014
WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transitionDuane H Hamilton, Bruce Huang, Romaine I Fernando, et al.
Seminars in Oncology|May 19, 2012
Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomasDuane H Hamilton, Mary T Litzinger, Romaine I Fernando, et al.
The Journal of Clinical Investigation|January 15, 2010
The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cellsRomaine I Fernando, Mary Litzinger, Paola Trono, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 24, 2011
Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cellsClaudia Palena, Romaine I Fernando, Mary T Litzinger, et al.
Molecular Cancer Therapeutics|June 21, 2013
An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotypeCecilia Larocca, Joseph R Cohen, Romaine I Fernando, et al.
Oncotarget|June 2, 2016
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinibRomaine I Fernando, Duane H Hamilton, Charli Dominguez, et al.
Pageof 4